These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 430379)

  • 1. Cardiac glycoside stimulation of inward Ca++ current in vascular smooth muscle of canine coronary artery.
    Belardinelli L; Harder D; Sperelakis N; Rubio R; Berne RM
    J Pharmacol Exp Ther; 1979 Apr; 209(1):62-6. PubMed ID: 430379
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cardiac glycosides on action potential characteristics and contractility in cat ventricular myocytes: role of calcium overload.
    Ruch SR; Nishio M; Wasserstrom JA
    J Pharmacol Exp Ther; 2003 Oct; 307(1):419-28. PubMed ID: 12954807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propafenone on TEA-induced action potentials in vascular smooth muscle of canine coronary arteries.
    Harder DR; Belardinelli L
    Experientia; 1980 Sep; 36(9):1082-3. PubMed ID: 7418845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of six cardiac glycosides on the transmembrane potential and contractile characteristics of the right ventricle of guinea pigs.
    Ito M; Hollander PB; Marks BH; Dutta S
    J Pharmacol Exp Ther; 1970 Mar; 172(1):188-95. PubMed ID: 5416942
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides.
    Fleckenstein A; Byon KY
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R20. PubMed ID: 4276541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcium-antagonism, a new principle in coronary vasodilation].
    Grün G; Fleckenstein A
    Minerva Med; 1975 May; 66(38):1838-45. PubMed ID: 805387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane electrical effects of histamine on vascular smooth muscle of canine coronary artery.
    Harder DR
    Circ Res; 1980 Mar; 46(3):372-7. PubMed ID: 7357692
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Augmentation of coronary smooth muscle tone and sensitization to Ca by cardiac glycosides.
    Grün G; Weder U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R28. PubMed ID: 4276553
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of AHR-2666 on electrical activity of canine cardiac tissues: possible inhibition of slow inward current.
    Siegal MS; Gliklich JI; Mary-Rabine L; Hoffman BF
    J Pharmacol Exp Ther; 1979 Dec; 211(3):606-14. PubMed ID: 512920
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of membrane properties in vascular muscle cells from various vascular beds.
    Harder DR
    Fed Proc; 1983 Feb; 42(2):253-6. PubMed ID: 6337065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacology of digitalis receptors].
    Godfraind T
    Bull Acad R Med Belg; 1972; 12():403-48. PubMed ID: 4267374
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased Ca 2+ entry during the plateau of the action potential: a possible mechanism of cardiac glycoside action.
    Katz AM
    J Mol Cell Cardiol; 1972 Feb; 4(1):87-9. PubMed ID: 4260012
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of tetraethylammonium on electrophysiologic properties of pulmonary artery smooth muscle cells].
    Gurkovskaia AV
    Biull Eksp Biol Med; 1977 Feb; 83(2):134-6. PubMed ID: 856337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of three types of K+ currents in canine coronary artery smooth muscle cells by NS-004, or 1-(2'-hydroxy-5'-chlorophenyl)-5-trifluoromethyl-2(3H) benzimidazolone.
    Xu X; Tsai TD; Wang J; Lee EW; Lee KS
    J Pharmacol Exp Ther; 1994 Oct; 271(1):362-9. PubMed ID: 7965736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac glycosides on interaction of Ca++ with mitochondria.
    Lee KS; Hong SA; Kang DH
    J Pharmacol Exp Ther; 1970 Mar; 172(1):180-7. PubMed ID: 5416941
    [No Abstract]   [Full Text] [Related]  

  • 17. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined therapy with glycosides and Ca++-antagonistic agents (author's transl)].
    Fleckenstein A; Fleckenstein-Grün G
    Arzneimittelforschung; 1977; 27(3a):736-42. PubMed ID: 577452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vagal role in potentiation by Ca2+ ions of the action of cardiac glycosides on the atrial specialised tissue.
    Lang J; Lakhal M; Timour Chah Q; Faucon G
    J Pharmacol; 1985; 16(2):125-37. PubMed ID: 4058011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nature of electromechanical connections in the smooth muscle cells of the pulmonary artery].
    Gurkovskaia AV; Shuba MF; Buryĭ VA
    Fiziol Zh SSSR Im I M Sechenova; 1983 Aug; 69(8):1065-73. PubMed ID: 6313438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.